Lobbying Information
Subject Matters
- Consumer Issues
- Economic Development
- Environment
- Health
- Industry
- Intellectual Property
- International Trade
- Regional Development
- Science and Technology
Subject Matter Details
Policies or Program
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
- Health Canada Health Products & Food Regulatory Modernization
- Health Canada policies with respect to Subsequent Entry Biologics
- Health Canada policies with respect to drug compounding and/or admixing
- International Trade Canada's Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
- Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
- Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
- Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
- Policies or programs with respect to Federal Public Drug Benefit Programs
- Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Regulation
- Canadian Environmental Protection Act Regulations with regard to the regulation of chemicals and toxic substances, specifically Bisphenol A, Bis ( 2-ETHYLHEXYL) Phthalate, Benzyl Butyl Phthalate and Dibutyl Phthalate
- Federal Chemicals Management Plan as it relates to the regulation of chemicals and toxic substances, specifically Bisphenol A, Bis ( 2-ETHYLHEXYL) Phthalate, Benzyl Butyl Phthalate and Dibutyl Phthalate
- Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
- Food and Drug Regulations with respect to Data Protection under. C.08.004
- Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices
- Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Environment and Climate Change Canada (ECCC)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Justice Canada (JC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
7125 Mississauga Rd.
MISSISSAUGA, ON L5N 0C2
Canada
Telephone number:
905-281-6489
Fax number:
905-281-6570
Client representative
Susan Berek, Director, Market Access & HEOR
Parent Company Information
- BAXTER
-
ONE BAXTER PARKWAY
DEERFIELD, IL 60015
United States of America
Coalition Members Information
BAXTER CORP. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of BAXTER CORP. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
BAXTER CORP. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
CARL BALTARE
|
Public offices held
Business address:
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
Consultant Firm and Address
Firm:
GLOBAL PUBLIC AFFAIRS
Address:
50 O'CONNOR ST. SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
